Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07044531 · ClinicalTrials.gov registry record · NA
Development OF A Novel Peer Recovery Supporter Training Platform
A NA study of Substance Use Disorders and Alcohol Use Disorders, sponsored by Thrive Digital Health.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07044531: Recruiting NA study of Substance Use Disorders and Alcohol Use Disorders, sponsored by Thrive Digital Health.
NCT07044531 is a NA study of Substance Use Disorders and Alcohol Use Disorders that is actively recruiting participants, run by Thrive Digital Health. The registered enrollment target is 120 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07044531, a NA study of Substance Use Disorders and Alcohol Use Disorders, is actively recruiting participants, sponsored by Thrive Digital Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The focus of this study is to assess the effect on Peer Recovery Support Service providers of the fully asynchronous training platform (TDPP) and the TDPP with live zoom sessions on skill and adherence compared with training-as-usual.
Primary Outcome
Assessed using the adapted Yale Adherence and Competence Scale II (YACS II), which measures skill adherence during simulated peer recovery support interactions. Each participant is scored by blinded, trained raters using a standardized coding protocol.
Conditions Studied
Interventions
- BEHAVIORAL Training-as-Usual (TAU)
- BEHAVIORAL TDPP-A (Asynchronous Platform)
- BEHAVIORAL TDPP-Z (Asynchronous + Zoom)
Study Locations (1)
Ohio
- Thrive Digital Health - Solon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-05-07 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT07044531 shows while recruiting
NCT07044531 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (76% lower).
The record links to 4 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 3 interventions - of which Training-as-Usual (TAU) is the first listed.
NCT07044531 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07044531 about?
NCT07044531 is a clinical study titled "Development OF A Novel Peer Recovery Supporter Training Platform". The focus of this study is to assess the effect on Peer Recovery Support Service providers of the fully asynchronous training platform (TDPP) and the TDPP with live zoom sessions on skill and adherence compared with training-as-usual.
What is the current status of trial NCT07044531?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-05-07. Estimated completion is 2026-07.
What conditions does trial NCT07044531 study?
This clinical trial studies the following conditions: Substance Use Disorders, Alcohol Use Disorders, Recovery Support Services, Peer Recovery Coaching.
What interventions are being tested in trial NCT07044531?
The interventions under investigation include: Training-as-Usual (TAU) (BEHAVIORAL), TDPP-A (Asynchronous Platform) (BEHAVIORAL), TDPP-Z (Asynchronous + Zoom) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07044531?
This trial is sponsored by Thrive Digital Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07044531 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07044531's enrollment target sits among peer trials
120 45th of 93 higher than 45 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
-
The Oklahoma Parent-Child Assistance Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI